Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Sergliflozin etabonate

Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.

Product Specifications

CAS Number

408504-26-7

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

448.468

Molecular Formula

C23H28O9

Notes

Research use only, not for human use.

Receptor

Protoporphyrinogen oxidase

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

HOXB7 (Homeobox B7, HHO.C1, HOX2, HOX2C, Hox-2.3) (HRP)
247219-HRP 100 µL

HOXB7 (Homeobox B7, HHO.C1, HOX2, HOX2C, Hox-2.3) (HRP)

Ask
View Details
Lentiviral human TAS1R2 shRNA (UAS) - Lentiviral human TAS1R2 shRNA (UAS) plasmid
GTR15325726 1 Vial

Lentiviral human TAS1R2 shRNA (UAS) - Lentiviral human TAS1R2 shRNA (UAS) plasmid

Ask
View Details
Mouse Caln1 Pre-designed siRNA Set A
SI101733A 1 Each

Mouse Caln1 Pre-designed siRNA Set A

Ask
View Details
Recombinant Bacillus subtilis Uncharacterized membrane protein yttA (yttA)
MBS7035548-01 0.02 mg

Recombinant Bacillus subtilis Uncharacterized membrane protein yttA (yttA)

Ask
View Details
Recombinant Bacillus subtilis Uncharacterized membrane protein yttA (yttA)
MBS7035548-02 0.1 mg

Recombinant Bacillus subtilis Uncharacterized membrane protein yttA (yttA)

Ask
View Details
Recombinant Bacillus subtilis Uncharacterized membrane protein yttA (yttA)
MBS7035548-03 5x 0.1 mg

Recombinant Bacillus subtilis Uncharacterized membrane protein yttA (yttA)

Ask
View Details